Skip to content
Research Article Open access CC BY 3.0

Pure Red Cell Aplasia in a Patient with Cri-Du-Chat

Jing Ai, Valeria Visconte, Heesun J. Rogers, Mikkael A. Sekeres, Ramon V. Tiu

International Blood Research & Reviews · pp. 23–28 · Published 28 Oct 2013

10.9734/IBRR/2014/6978

Abstract

Background: The Cri-Du-Chat syndrome also known as 5p- syndrome is a rare genetic autosomal disorder with the characteristic deletion of the short arm (p) of chromosome 5.  To date, hematologic manifestations characteristic of BM failure have not been linked to this syndrome.  Aims: To evaluate the safety and efficacy of cyclosporine to treat pure red cell aplasia in the clinical setting of 5p- syndrome.  Presentation of Case: We report here a patient with 5p- syndrome who subsequently developed idiopathic pure red cell aplasia. He was treated with cyclosporine 1mg/kg twice a day, and achieved a complete remission, with no toxicities.  Conclusion: This case suggests that cyclosporine can be used safely and effectively in such clinical scenario.  

Cri-Du-chat syndrome pure red cell aplasia cyclosporine

References (19)

  1. 1 Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia [DOI]
  2. 2 Acquired pure red cell aplasia: updated review of treatment [DOI]
  3. 3 Cri du Chat syndrome [DOI]
  4. 4 Pure red cell aplasia [DOI]
  5. 5 Molecular and phenotypic mapping of the short arm of chromosome 5: sublocalization of the critical region for the cri-du-chat syndrome [DOI]
  6. 6 Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities [see comments] [DOI]
  7. 7 Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study Group [DOI]
  8. 8 Diagnosis and Management of Acquired Pure Red Cell Aplasia [DOI]
  9. 9 Emerging roles for telomerase in neuronal development and apoptosis [DOI]
  10. 10 Five novel genes from the cri-du-chat critical region isolated by direct selection [DOI]
  11. 11 Alemtuzumab induced complete remission of therapy-resistant pure red cell aplasia [DOI]
  12. 12 Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p– syndrome [DOI]
  13. 13 Pure red-cell aplasia secondary to pregnancy, characterization of a syndrome [DOI]
  14. 14 Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients [DOI]
  15. 15 Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab [DOI]
  16. 16 Pure red cell aplasia of pregnancy: a distinct clinical entity [DOI]
  17. 17 Pure red cell aplasia: Response to therapy with anti‐thymocyte globulin [DOI]
  18. 18 A case of pure red cell aplasia and immune thrombocytopenia complicating systemic lupus erythematosus: Responseto rituximab and cyclophosphamide [DOI]
  19. 19 Pure red cell aplasia: Review of treatment and proposal for a treatment strategy [DOI]

Cited by 2

Myelodysplastic syndromes in a pediatric patient with Cri du Chat syndrome with a ring chromosome 5

Akifumi Nozawa, Michio Ozeki, Shiho Yasue · International Journal of Hematology · 2020

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

34

Page views

0

PDF downloads

4

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.